CHICAGO --- A Northwestern University researcher has developed the first truly reliable measure of neurobehavioral functioning during coma from severe brain injury that predicts recovery of consciousness up to one year after injury, with up to 86 percent certainty.
Theresa Louise-Bender Pape, assistant research professor of physical medicine and rehabilitation at Northwestern University Feinberg School of Medicine, and her colleagues described the measure, called Disorders of Consciousness Scale (DOCS) in a two-part series in the January/February 2005 issue of the Journal of Rehabilitation Research & Development.
Using the DOCS, the researchers evaluated military veterans and civilians over age 18 years who were unconscious after a severe brain injury. The test stimuli were organized into eight subscales, including social knowledge; taste and swallowing; olfactory; proprioceptive (perception of one's body in space) and vestibular (balance); auditory; visual; tactile; and testing-readiness.
The investigators found that DOCS accurately detected improvements, declines and plateaus in neurobehavioral functioning in unconscious patients.
The study also showed how repeated measures using DOCS improved medical and rehabilitation management during coma recovery. The investigators found previously undetected secondary medical complications, which were successfully treated.
Pape is also researcher at the Edward Hines, Jr., Veterans Administration Hospital, Hines, Ill., and at Marianjoy Rehabilitation Hospital, Wheaton, Ill. Investigators from the Rehabilitation Institute of Chicago collaborated on the research.
The study was based on work supported by grants from the Department of Veterans Affairs, Veterans Health Administration; the Midwest Center for Health Services and Policy Research; and the National Institute on Disability and Rehabilitation Research.
'"/>
Contact: Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
9-Mar-2005
Page: 1 Related medicine news :1.
Nanoscale diagnostic sets sights on Alzheimers2.
New type of anthrax vaccine moves into larger-scale trial at Saint Louis University3.
Large-scale analysis of women with androgen excess: thorough treatment can reduce symptoms4.
Post-genomic technique provides real-time, multiscale look at protein life cycles in living cells5.
Submicrometer-scale metallic barcodes described by Penn State and Surromed6.
Big plans on a small scale: NSF funds centers for nanoscale research7.
First large-scale clinical study establishes the efficacy of the new oral anticoagulant H 376/958.
New evaluation tool reliably predicts recovery from coma9.
Computational tool predicts how drugs work in cells, advancing efforts to design better medicines10.
Depression predicts heart rhythm abnormalities in heart attack patients11.
A shallow hip socket predicts osteoarthritis of the hip